泊沙康唑中间体1 - CAS:149809-43-8 - 研锐化学-溶剂、试剂、原料、耗材、仪器、[研化商城]

泊沙康唑中间体1

英文名： (3S,5R)-5-(2,4-Difluorophenyl)-5-[(1H-1,2,4-triazol-1-yl)methyl]oxolan-3-ylmethyl p-Toluenesulfonate 别名：(5R-cis)-甲苯-4-磺酸 5-(2,4-二氟苯基)-5-(1H-1,2,4-三氮唑-1-基)甲基四氢呋喃-3-基甲基酯;对甲基苯磺酸(3S,5R)-5-(2,4-二氟苯基)-5-[(1H-1,2,4-三唑-1-基)甲基]恶烷-3-基甲酯;((3R,5R)-5-((1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基4-甲基苯磺酸酯;(5R-cis)-***-4-磺酸 5-(2,4-二氟苯基)-5-(1H-1,2,4-三氮唑-1-基)甲基四氢呋喃-3-基甲基酯;泊沙对甲主环;泊沙康唑;泊沙康唑中间体1;泊沙康唑中间体12;泊沙康唑主环;羟甲基磷酸;泊沙康唑中间体A;((3R,5R)-5-((1H-1,2,4-三氮唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基4-甲基苯磺酸盐;(5R-CIS)-甲苯-4-磺酸 5-(2,4-二氟苯基)-5-(1H-1,2,4-三氮唑-1-基);(5R-cis)-甲苯-4-磺酸-5-(2,4-二氟苯基)-5-(1H-1,2,4-三氮唑-1-基)甲基四氢呋喃-3-基甲基酯;泊沙康唑-1;泊沙主环;泊沙康唑杂质53;泊沙康唑中间体POA;泊沙康唑主环(含对甲苯磺酸);泊沙康唑杂质13;泊沙康唑/泊沙康唑主环

商品编号：R031330-250mg 规格：250mg 纯度：≥97%

CAS号： 149809-43-8 分子式：C21H21F2N3O4S 分子量：449.47

价格	¥ 510.00 （请登录会员查看折扣价）
货期	5~7个工作日

数量

中文名称：	泊沙康唑中间体1
中文别名：	(5R-cis)-甲苯-4-磺酸 5-(2,4-二氟苯基)-5-(1H-1,2,4-三氮唑-1-基)甲基四氢呋喃-3-基甲基酯;对甲基苯磺酸(3S,5R)-5-(2,4-二氟苯基)-5-[(1H-1,2,4-三唑-1-基)甲基]恶烷-3-基甲酯;((3R,5R)-5-((1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基4-甲基苯磺酸酯;(5R-cis)-***-4-磺酸 5-(2,4-二氟苯基)-5-(1H-1,2,4-三氮唑-1-基)甲基四氢呋喃-3-基甲基酯;泊沙对甲主环;泊沙康唑;泊沙康唑中间体1;泊沙康唑中间体12;泊沙康唑主环;羟甲基磷酸;泊沙康唑中间体A;((3R,5R)-5-((1H-1,2,4-三氮唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基4-甲基苯磺酸盐;(5R-CIS)-甲苯-4-磺酸 5-(2,4-二氟苯基)-5-(1H-1,2,4-三氮唑-1-基);(5R-cis)-甲苯-4-磺酸-5-(2,4-二氟苯基)-5-(1H-1,2,4-三氮唑-1-基)甲基四氢呋喃-3-基甲基酯;泊沙康唑-1;泊沙主环;泊沙康唑杂质53;泊沙康唑中间体POA;泊沙康唑主环(含对甲苯磺酸);泊沙康唑杂质13;泊沙康唑/泊沙康唑主环
smiles：	S(C1C([H])=C([H])C(C([H])([H])[H])=C([H])C=1[H])(=O)(=O)OC([H])([H])[C@@]1([H])C([H])([H])O[C@@](C2C([H])=C([H])C(=C([H])C=2F)F)(C([H])([H])N2C([H])=NC([H])=N2)C1([H])[H]
英文名称：	(3S,5R)-5-(2,4-Difluorophenyl)-5-[(1H-1,2,4-triazol-1-yl)methyl]oxolan-3-ylmethyl p-Toluenesulfonate
英文别名：	((3R,5R)-5-((1H-1,2,4-Triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl 4-methylbenzenesulfonate;(5R-cis)-Toluene-4-sulfonic Acid 5-(2,4-Difluorophenyl)-5-[1,2,4]triazol- 1-ylmethyltetrahydrofuran-3-ylmethyl Ester;(3S,5R)-5-(2,4-Difluorophenyl)-5-[(1H-1,2,4-triazol-1-yl)methyl]oxolan-3-ylmethyl p-Toluenesulfonate;(5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethylester;(5R-cis)-Toluene-4-s;(5R-cis)-Toluene-4-sulfonic Acid 5-(2,4-Difluorophenyl)-5-[1,2,4]triazol- 1-ylmethyltetrahydrofuran-3-ylmethyl Ester;[(3S,5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methyl 4-methylbenzenesulfonate;5-(2,4-Difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester;D-threo-Pentitol, 2,5-anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-[[[(4-methylphenyl)sulfonyl]oxy]methyl]-1-(1H-1,2,4-triazol-1-yl)-;Posaconazole inter-1;6-Methoxyaromadendrin 3-O-acetate;p-Toluenesulfonic Acid (3S,5R)-5-(2,4-Difluorophenyl)-5-[(1H-1,2,4-triazol-1-yl)methyl]oxolan-3-ylmethyl Ester;Posaconazole int1;Posaconazole Main Ring;Posaconazole Impurity 53;Posaconazole InterMediate;Posaconazole InterMediates;Posaconazole Intermediate1;Posazonazole intermediate POA;(5R-cis)-Toluene-4-sulfonic acid;(5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4;L-threo-Pentitol,2,5-anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-[[[(4-Methylphenyl)sulfonyl]oxy]Methyl]-1-(1H-1,2,4-triazol-1-yl)-;[(3R,5S)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methyl 4-methylbenzenesulfonate;p-Toluenesulfonic acid [5-(2,4-difluorophenyl)-5alpha-(1H-1,2,4-triazol-1-ylmethyl)tetrahydrofuran]-3alpha-ylmethyl ester;posaconazole impurity 13;(5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester;(5-((1H-1,2,4-Triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl 4-methylbenzenesulfonate, (3S,5R)-;D4537;(5R-cis)-Toluene-4-sulfonic Acid 5-(2,4-Difluorophenyl)-5-[1,2,4]triazol-;((3S,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluoro phenyl)tetrahydrofuran-3-yl)methyl 4-methylbenzenesulfonate;(5R-cis)-Toluene-4-sulfonic Acid 5-(2,4-Difluorophenyl)-5-[1,2,4]triazol-1-ylmethyltetrahydrofuran-3;UNII-LDY4QZP8PB;DTXSID70447488;1-ylmethyltetrahydrofuran-3-ylmethyl Ester;149809-43-8;((3S,5R)-5-((1H-1,2,4-triazol-1-yl)Methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)Methyl 4-Methylbenzenesulfonate;[(3S,5R)-5-(2,4-DIFLUOROPHENYL)-5-(1,2,4-TRIAZOL-1-YLMETHYL)OXOLAN-3-YL]METHYL 4-METHYLBENZENESULFONATE;2,5-Anhydro-1,3,4-trideoxy-2-(2,4-difluorophenyl)-4-{[(4-methylbenzene-1-sulfonyl)oxy]methyl}-1-(1H-1,2,4-triazol-1-yl)-D-threo-pentitol;CS-M2899;AKOS025402355;2,5-Anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-((((4-methylphenyl)sulfonyl)oxy)methyl)-1-(1H-1,2,4-triazol-1-y...
CAS号：	149809-43-8
分子式：	C21H21F2N3O4S
分子量：	449.47
密度：
熔点：
沸点：
闪点：
水溶性：
蒸气压：

搜索质检报告(COA)

搜索MSDS